SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-007472
Filing Date
2017-01-11
Accepted
2017-01-11 09:00:32
Documents
4
Period of Report
2017-01-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d272311d8k.htm 8-K 16793
2 EX-3.1 d272311dex31.htm EX-3.1 4334
3 EX-99.1 d272311dex991.htm EX-99.1 8304
4 GRAPHIC g272311g37o14.jpg GRAPHIC 14611
  Complete submission text file 0001193125-17-007472.txt   50981
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 17522041
SIC: 2834 Pharmaceutical Preparations